| Company Name: | Adolor Corporation | | Ticker Symbol: | ADLR | | | WWW Address: | www.adolor.com |
| CEO: | Michael R. Dougherty | | No. of Employees: | 75 |
| Common Issue Type: | CS | | Business Description: | Adolor Corporation is a biopharmaceutical company, which focused on the discovery, development and commercialization of novel prescription pain management products.
|
| | | Industry Information: | DRUGS - Drug Manufacturers - Other [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 4.77 |  0.0 | - | - | | 4.77 | 4.77 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 222.3 | 46.6 | 1.39 | -0.59 | 0.00 | 0.0 | 0.0 | 4.83 - 1.11 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 4.77 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 222.3 | mil |
| Latest Shares Outstanding | 46.6 | mil |
| Earnings pS (EPS) | -0.59 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 577,367 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 31.9 | mil |
| Float as % of Shares Outstanding | 68.8 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 58.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 44.20 | % |
| Gross Profit Margin | 49.1 | % |
| EBITDA Margin | -53.4 | % |
| Pre-Tax Profit Margin | -5.9 | % |
| Assets Turnover | 1.1 | % |
| Return on Assets (ROA) | -7.3 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -16.6 | % |
| Current Ratio | 2.3 | |
| Leverage Ratio (Assets/Equity) | 2.3 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 0.34 | $ |
| Cash pS | 0.28 | $ |
| Book-Value pS | 0.45 | $ |
| Tangible Book-Value pS | 0.04 | $ |
| Cash Flow pS | -0.64 | $ |
| Free Cash Flow pS | -0.60 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 10.55 | |
| Price/Tangible Book Ratio | 118.49 | |
| Price/Cash Flow | -7.4 | |
| Price/Free Cash Flow | -7.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 102 | 6,742 | |
| 4 Weeks | 4.83 | 4.56 | 4.67 | 2.1 | 100 | 5,397 | 80,959 |
| 13 Weeks | 4.83 | 1.50 | 2.03 | 135.0 | 231 | 7,167 | 430,044 |
| 26 Weeks | 4.83 | 1.50 | 1.89 | 152.4 | 260 | 5,164 | 635,190 |
| 52 Weeks | 4.83 | 1.11 | 1.17 | 307.7 | 410 | 3,162 | 784,265 |
| YTD | 4.83 | 1.22 | - | 294.2 | 401 | 3,187 | 761,637 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 4.75 | 4.71 | 4.01 | 2.66 | 2.31 | 1.39 | 1.91 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 35.64 | 62.9 | 4.66 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -40.96 | NA | -59.56 |
| R&D | -11.17 | NA | -17.21 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 49.1 | 133.4 | 15.9 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.52 | 0.32 | 0.44 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 72.68 |
| Current Ratio | 3.8 |
| Quick Ratio (Acid Test) | 3.6 |
| Liquidity Ratio (Cash) | 3.37 |
| Receivables Turnover | 12.5 |
| Average Collection Period | 29 |
| Working Capital/Equity | 195.1 |
| Working Capital pS | 0.83 |
| Cash-Flow pS | -0.87 |
| Free Cash-Flow pS | -0.79 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.27 |
| Financial Leverage Ratio (Assets/Equity) | 2.7 |
| Debt Ratio | 62.7 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 98.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 10.69 |
| Tobin's Q Ratio | 4.21 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -5.23 |
| Enterprise Value (EV)/Free Cash Flow | -5.96 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 118.49 |
| Price/Book Ratio - LTM | 10.55 |
| Price/Cash Flow Ratio | -7.4 |
| Price/Free Cash Flow Ratio - LTM | -7.9 |
| Price/Sales Ratio | 3.76 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.30 |
| Tangible Book Value pS - LTM | 0.04 |
| Book Value pS - LTM | 0.45 |
| Capital Invested pS | 0.42 |
| Cash pS - LTM | 0.28 |
| Cash Flow pS - LTM | -0.64 |
| Free Cash Flow pS - LTM | -0.60 |
| Earnings pS (EPS) | -0.59 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -84.83 |
| Free Cash Flow Margin 5YEAR AVG | -183.60 |
| Net Profit Margin | -63.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 2.20 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 2.20 |
| Return on Capital Invested (ROCI) | -138.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -53.5 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | -51.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | -33.5 |
| Gross Profit Margin | 49.1 |
| Gross Profit Margin - 5YEAR AVRG. | 85.8 |
| EBITDA Margin - LTM | -53.4 |
| EBIT Margin - LTM | -5.7 |
| Pre-Tax Profit Margin | -63.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.0 |
| Effective Tax Rate | 0.0 |
| Effective Tax Rate - 5YEAR AVRG. | 0.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 48 |
| Revenue per Employee | 577,367 |
| Net Income per Employee | -363,654 |
| Average Collection Period | 26 |
| Receivables Turnover | 12.5 |
| Day's Inventory Turnover Ratio | 22 |
| Inventory Turnover | 16.4 |
| Inventory/Sales | 2.2 |
| Accounts Payble/Sales | 0.63 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 1.13 |
| Fixed Assets Turnover | 75.83 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 9.41 |
| Revenue per $ Plant | 93.31 |
| Revenue per $ Common Equity | 2.20 |
| Revenue per $ Capital Invested | 2.20 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 78.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 106.1 |
| Research & Devlopment (R&D) as % of Revenue | 76.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 76.7 |
|
|  
|
| |
 |  |
